Table 5.

Univariate regression and receiver operator characteristics (ROC) results for the study cohort excluding amyloid cases.

Covariate	HR	95% CI of HR	AUC	95% CI of AUC	p
Clinical characteristics
Age (years)	1.35	0.7957–2.3037	0.581	0.426–0.737	0.31
Gender	0.66	0.2606–1.6952	0.538	0.418–0.654	0.57
BMI (kg/m2)	0.40	0.1866–0.8493	0.662	0.539–0.771	0.03
Atrial fibrillation	0.53	0.1745–1.6233	0.568	0.448–0.683	0.27
Hypertension	0.95	0.2749–3.2910	0.533	0.413–0.650	0.54
Coronary artery disease	2.52	0.9949–6.4070	0.618	0.497–0.728	0.08
Myocardial infarction	1.22	0.3516–4.2249	0.524	0.405–0.642	0.61
Diabetes mellitus	0.49	0.1120–2.1794	0.554	0.433–0.670	0.26
COPD	1.16	0.3282–4.0880	0.503	0.384–0.621	0.95
Smoker	0.85	0.3294–2.2152	0.526	0.406–0.643	0.7
Haemoglobin (g/L)	0.75	0.4685–1.1959	0.599	0.478–0.713	0.16
Blood urea (mmol/L)	1.01	0.6263–1.6288	0.506	0.386–0.625	0.94
Serum creatinine (µmol/L)	1.35	0.8511–2.1292	0.573	0.451–0.688	0.37
eGFR (mL/min/1.73 m2)	0.75	0.4543–1.2269	0.573	0.451–0.688	0.35
NTproBNP (pg/mL)	1.72	1.2886–2.2894	0.668	0.543–0.779	0.06
Left heart assessment
LV end-diastolic volume (mL)	1.23	0.7460–2.0413	0.541	0.420–0.659	0.62
LV end-systolic volume (mL)	1.20	0.7316–1.9687	0.54	0.419–0.658	0.61
LV stroke volume (mL)	1.15	0.6940–1.8971	0.509	0.389–0.629	0.9
LV ejection fraction (%)	0.96	0.5764–1.6117	0.548	0.427–0.666	0.49
LV mass (g)	1.44	0.9549–2.1860	0.598	0.476–0.712	0.23
Scar core (%)	0.88	0.4845–1.5961	0.575	0.446–0.697	0.41
Fibrosis (%)	1.33	0.7816–2.2540	0.569	0.441–0.692	0.44
Native T1-values (ms)	2.84	1.0585–7.6449	0.833	0.656–0.942	< 0.01
Right heart assessment
RV end-diastolic volume (mL)	1.23	0.7629–1.9865	0.573	0.451–0.689	0.4
RV end-systolic volume (mL)	1.18	0.7729–1.7983	0.559	0.437–0.676	0.47
RV stroke volume (mL)	1.04	0.6149–1.7567	0.544	0.423–0.662	0.59
RV ejection fraction (%)	0.75	0.4639–1.2231	0.558	0.436–0.675	0.4
RV Mass (g)	1.02	0.6748–1.5478	0.551	0.430–0.669	0.55